News
Categories
Sign up
Featured Posts
Archive
- September 2020
- June 2020
- April 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- July 2019
- June 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- May 2018
- April 2018
- March 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- July 2017
- May 2017
- April 2017
- February 2017
- January 2017
Follow Us
Alpha Tau Medical avvia la prima sperimentazione clinica in Italia per la cura del tumore con le rad
Alpha Tau Medical è lieta di annunciare l’avvio della sua prima sperimentazione clinica in Italia. Lo studio che sarà condotto presso l’IRST, a Meldola, valuterà la fattibilità, la sicurezza e l’efficacia della terapia Alpha DaRT per il trattamento del carcinoma a cellule squamose (SCC) della pelle (tumore della pelle). L’equipe spera che i risultati ottenuti dallo studio condotto presso l’IRST rafforzeranno ulteriormente gli incoraggianti esiti preliminari dello studio dedicato all’SCC tuttora in corso presso il Rabin Medical Center, in Israele. “Si tratta di un’occasione importante per ampliare il nostro progetto e maturare esperienza e riconoscimento a livello internazionale. Siamo entusi
Die klinische Studie am IRST in Italien wird die Sicherheit, Ausführbarkeit und Wirksamkeit von Alpha DaRT zur Behandlung von spinozellulären Karzinomen (SZK) der Haut untersuchen. Alpha Tau Medical verkündet freudig ihre erste klinische Studie in Italien. Die Studie am IRST in Meldola wird die Machbarkeit, Sicherheit und Wirksamkeit von Alpha DaRT zur Behandlung von spinozellulären Karzinomen (SZK) der Haut (Hautkrebs) untersuchen. Von den Befunden dieser Studie erhofft sich das Team, die vielversprechenden vorläufigen Ergebnisse der laufenden SZK-Studie am Rabin Medical Center Israel zu untermauern. “This is a significant opportunity for our project to expand and gain international experie
Alpha Tau Medical is now initiating its Alpha DaRT clinical trial at IRST, Italy. The great team at IRST and Prof. Yona Keisari as well as Amnon Gat are excited about this opportunity to study the efficacy of Alpha DaRT in cancer patients suffering from Squamous Cell Carcinoma (SCC) of the skin. The revolutionary radiotherapy treatment enables a highly potent and specific targeting of solid tumors. Clinical trials in Israel showed highly promising results and the team strives to help millions of patients around the world. IRST (Instituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori) was founded in 2007 and is situated in Meldola, Italy. The Centre is known for its excellent cance